Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Mosaic ImmunoEngineering Inc. logo — Advancing novel immunostimulatory nanoparticles for the trea...

Mosaic ImmunoEngineering Inc.

Advancing novel immunostimulatory nanoparticles for the treatment and prevention of cancer and infectious diseases

Founded 2020 7 employees Biotechnology, Health Care

General Information

Company Name Mosaic ImmunoEngineering Inc.
Founded Year 2020
Employees 7
Industries Biotechnology, Health Care
Social

Get notified when Mosaic ImmunoEngineering Inc. moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Mosaic ImmunoEngineering Inc.

Mosaic ImmunoEngineering Inc. is a development-stage biotechnology company focused on bridging immunology and engineering to develop novel immunotherapies to treat and prevent cancer and infectious diseases. Our core technology is derived from a plant virus, cowpea mosaic virus ("CPMV") which is non-infectious to humans or other animals but upon intratumoral administration is recognized by immune cells as foreign, eliciting a strong local innate immune response through the activation of multiple toll-like receptors (TLRs). In oncology indications, this TLR activation results in potent anti-tumor activity against the primary and distant tumor sites. Our lead candidate, MIE-101, has demonstrated broad and consistent antitumor activity as a single agent and when combined with standard treatments in multiple preclinical tumor models as well as in canine companion animals with advanced cancer. Research investigating this first-in-class intratumoral multi-TLR agonist continues to be supported by numerous publications and grant funding through our university collaborators. Our technology is also being investigated as part of a modular vaccine platform, utilizing CPMV as an immune stimulant linked with viral or cancer antigens. Data generated to date show promising results in both cancer and infectious disease preclinical vaccine models, including COVID-19. The vaccine research is currently being performed by one of our co-founders and is funded by the National Science Foundation with viral neutralization testing being performed by the National Institute of Allergy and Infectious Diseases (NIAID). ​ We are actively moving our unique technology platforms forward with the goal of filing an investigational new drug (IND) or similar application for oncology indications with the appropriate regulatory authorities to initiate clinical development of our lead candidates. Our goal is to advance our technology into veterinary and human studies in 2022.

No funding data available for Mosaic ImmunoEngineering Inc. yet.

Get notified when Mosaic ImmunoEngineering Inc. raises funding

Mosaic ImmunoEngineering Inc. Alternatives & Competitors

Mosaic ImmunoEngineering Inc. vs
Virion Therapeutics, LLC
Virion Therapeutics, LLC United States

T CELL-BASED IMMUNOTHERAPIES FOR CANCER AND INFECTIOUS DISEASES

Series Unknown
8 employees
Biotechnology, Health Care

FAQ About Mosaic ImmunoEngineering Inc.

Advancing novel immunostimulatory nanoparticles for the treatment and prevention of cancer and infectious diseases
Mosaic ImmunoEngineering Inc. was founded in 2020.
Mosaic ImmunoEngineering Inc. operates in the following industries: Biotechnology, Health Care.
Mosaic ImmunoEngineering Inc. has approximately 7 employees.
Top alternatives and competitors to Mosaic ImmunoEngineering Inc. include Virion Therapeutics, LLC. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Mosaic ImmunoEngineering Inc. and Virion Therapeutics, LLC are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Mosaic ImmunoEngineering Inc. and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy